| 000 | 01381 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514023343.0 | ||
| 264 | 0 | _c20020325 | |
| 008 | 200203s 0 0 ger d | ||
| 022 | _a0723-5003 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFischer, Thomas | |
| 245 | 0 | 0 |
_a[Results up to now of administration of STI-571 (Glivec) in recurrence after allogenic and autologous stem cell transplantation in chronic myeloid leukemia]. _h[electronic resource] |
| 260 |
_bMedizinische Klinik (Munich, Germany : 1983) _cJan 2002 |
||
| 300 |
_a22-7 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPiperazines _xadverse effects |
| 650 | 0 | 4 |
_aPyrimidines _xadverse effects |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tMedizinische Klinik (Munich, Germany : 1983) _gvol. 97 Suppl 1 _gp. 22-7 |
|
| 999 |
_c11740267 _d11740267 |
||